The COVID-19 Immunity Task Force will study the prevalence of COVID-19 antibodies among Canadians over 50 years old; Dr. Mona Nemer is appointed to a second term as Chief Science Officer, and digital health technology continues to accelerate in Canada.
Topic: CanCOVID-19
Canada’s chief science officer highlights office’s responses to pandemic
Dr. Mona Nemer appeared before the House of Commons Standing Committee on Health May 19 to highlight what her office has been doing since the novel coronavirus arrived in Canada.